Ensuring lifesaving pneumonia treatment reaches children in Tanzania
What does it take to move a lifesaving medicine from donor dependence to sustainable domestic financing and reliable access? For more than a decade, R4D partnered with the Government of Tanzania to strengthen the market for amoxicillin dispersible tablets (Amox DT), the recommended first-line treatment for childhood pneumonia. Today, procurement is fully domestically financed, the number of registered suppliers has grown from one to eight, supply planning is digitized within the national Medical Stores Department, and availability in public facilities has risen from 48% to 93%. This impact brief explores how these milestones were achieved — and what they mean for sustaining access to lifesaving treatment.
